Sanara MedTech
SMTI
35 hedge funds and large institutions have $19.1M invested in Sanara MedTech in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 4
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
13% more funds holding
Funds holding: 31 → 35 (+4)
10% more capital invested
Capital invested by funds: $17.4M → $19.1M (+$1.71M)
0.92% more ownership
Funds ownership: 4.6% → 5.52% (+0.92%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.28M |
| 2 |
Jane Street
New York
|
+$742K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$469K |
| 4 |
HF
HRT Financial
New York
|
+$463K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$425K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$708K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$268K |
| 3 |
6CM
683 Capital Management
New York
|
-$226K |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$211K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$98K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $194K | +$167K | +3,952 | +521% |
|
27
JP Morgan Chase
New York
| $131K | +$134K | +3,173 | New |
|
28
First Manhattan
New York
| $70.1K | – | – | – |
|
29
UBS Group
Zurich,
Switzerland
| $25.1K | +$14.9K | +354 | +139% |
|
|
ARS
30
Adirondack Retirement Specialists
Queensbury,
New York
| $24.8K | – | – | – |
|
|
LF
31
Lee Financial
Dallas,
Texas
| $20.6K | – | – | – |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $19K | -$1.6K | -38 | -7% |
|
33
Osaic Holdings
Scottsdale,
Arizona
| $5.07K | – | – | – |
|
|
SIS
34
Strategic Investment Solutions
Orland Park,
Illinois
| $4.13K | +$4.22K | +100 | New |
|
35
Wells Fargo
San Francisco,
California
| $866 | – | – | – |
|
|
36
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$268K | -5,900 | Closed |
|
|
6CM
37
683 Capital Management
New York
| – | -$226K | -4,966 | Closed |
|
SMTI Hedge Fund Activity: Q1 2023 in Review
35 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q1 2023, worth a combined $19.1M — up 9.9% from $17.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SMTI positions and 2 closed out — a net gain of 5 holders — while 16 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.28M. The largest seller was EAM Investors, cutting an estimated $708K.
- 35 institutional investors held Sanara MedTech (SMTI) as of Q1 2023, up from 31 in Q4 2022.
- Funds reported $19.1M of Sanara MedTech stock for Q1 2023, up 9.9% quarter-over-quarter.
- 7 funds opened new Sanara MedTech positions in Q1 2023 and 2 closed out, a net change of +5 holders.
- The largest Sanara MedTech buyer in Q1 2023 was Millennium Management, an estimated $1.28M added.
- The largest Sanara MedTech seller in Q1 2023 was EAM Investors, an estimated $708K sold.
Based on aggregated 13F filings for Q1 2023.